Phreesia (NYSE:PHR) Price Target Lowered to $22.00 at Canaccord Genuity Group

Phreesia (NYSE:PHR) had its price objective cut by equities research analysts at Canaccord Genuity Group from $33.00 to $22.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would indicate a potential upside of 92.41% from the company’s previous close.

A number of other research analysts also recently issued reports on PHR. Wells Fargo & Company dropped their price objective on Phreesia from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, March 26th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a report on Wednesday, January 28th. Mizuho dropped their price target on Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. Needham & Company LLC cut their price target on Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday. Finally, Truist Financial reaffirmed a “hold” rating and set a $11.00 price objective on shares of Phreesia in a research report on Tuesday. Thirteen analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $22.71.

Phreesia Price Performance

Shares of NYSE PHR opened at $11.43 on Tuesday. The company has a market capitalization of $689.36 million, a PE ratio of -114.33 and a beta of 0.67. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01. Phreesia has a twelve month low of $10.75 and a twelve month high of $32.76. The firm has a fifty day simple moving average of $12.51 and a 200 day simple moving average of $17.68.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm had revenue of $127.07 million for the quarter, compared to the consensus estimate of $126.75 million. During the same period last year, the company posted ($0.11) EPS. The business’s revenue was up 15.9% compared to the same quarter last year. On average, sell-side analysts forecast that Phreesia will post -1.1 EPS for the current year.

Insider Buying and Selling

In other Phreesia news, SVP Amy Beth Vanduyn sold 2,202 shares of the stock in a transaction that occurred on Friday, January 16th. The stock was sold at an average price of $16.36, for a total value of $36,024.72. Following the transaction, the senior vice president owned 157,349 shares in the company, valued at approximately $2,574,229.64. This represents a 1.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Allison C. Hoffman sold 6,176 shares of the business’s stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $11.97, for a total value of $73,926.72. Following the sale, the general counsel owned 163,485 shares of the company’s stock, valued at approximately $1,956,915.45. This represents a 3.64% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 70,358 shares of company stock worth $1,123,569 over the last 90 days. 5.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PHR. Federated Hermes Inc. acquired a new position in shares of Phreesia during the third quarter valued at about $32,000. Asset Management One Co. Ltd. bought a new position in Phreesia in the 3rd quarter valued at about $45,000. Van ECK Associates Corp boosted its stake in Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after purchasing an additional 1,102 shares during the last quarter. Rockefeller Capital Management L.P. increased its holdings in Phreesia by 354.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after purchasing an additional 2,149 shares in the last quarter. Finally, KBC Group NV raised its stake in shares of Phreesia by 83.4% in the fourth quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after purchasing an additional 1,568 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Company reported positive GAAP net income and strong free cash flow for the fiscal year — exceeded internal targets including crossing $100M of Adjusted EBITDA and roughly $50M+ of free cash flow, a proof point for profitability and capital-generation that can support valuation. Phreesia Announces Fourth Quarter Fiscal 2026 Results
• Positive Sentiment: Management highlighted record revenue growth and strategic initiatives on the Q4 call, indicating underlying demand and execution on product/partnership priorities that investors view as longer-term upside. Phreesia Inc (PHR) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic …
• Neutral Sentiment: Full earnings-call transcript is available for detail seekers — useful for investors who want management’s color on drivers, margin improvement, and the AccessOne integration timeline. Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
• Neutral Sentiment: Several analysts revised expectations heading into the print, lowering EPS/forecast assumptions — shows sentiment was already shifting and likely amplified intraday moves. Top Wall Street Forecasters Revamp Phreesia Expectations Ahead Of Q4 Earnings
• Negative Sentiment: Management cut near-term outlook: FY2027 revenue was guided to $510M–$520M and executives warned of headwinds from the network solutions business and integration-related pressure from AccessOne — a driver of the recent sell-off. Phreesia outlines $510M–$520M revenue target for 2027 amid network solutions headwinds and AccessOne integration
• Negative Sentiment: Market reaction: shares plunged after the EPS miss and guidance cut (reports of a ~22% drop and all-time lows in some sessions) — short-term momentum and sentiment risk remain. Phreesia shares tumble 22% on earnings miss, slashed guidance

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.